We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$239M
AUM Growth
+$8.32M
Cap. Flow
-$5.16M
Cap. Flow %
-2.16%
Top 10 Hldgs %
35.11%
Holding
546
New
36
Increased
93
Reduced
108
Closed
33

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.4M
2
EOG icon
EOG Resources
EOG
+$2.91M
3
UTHR icon
United Therapeutics
UTHR
+$2.5M
4
ZBRA icon
Zebra Technologies
ZBRA
+$1.98M
5
PVH icon
PVH
PVH
+$1.43M

Sector Composition

Rank Sector Weight
1 Financials 10.55%
2 Consumer Staples 7.28%
3 Technology 6.91%
4 Consumer Discretionary 6.75%
5 Industrials 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTV icon
51
Vanguard Morningstar Value ETF
VTV
$188B
$890K 0.37%
+7,422
New +$857K
AAPL icon
52
Apple
AAPL
$4.54T
$884K 0.37%
12,036
-1,032
-8% -$66.4K
DLR icon
53
Digital Realty Trust
DLR
$69.7B
$874K 0.37%
7,303
JNJ icon
54
Johnson & Johnson
JNJ
$618B
$846K 0.35%
5,799
+75
+1% +$10.2K
IWM icon
55
iShares Russell 2000 ETF
IWM
$79.8B
$800K 0.33%
4,828
-57
-1% -$9.01K
ADBE icon
56
Adobe
ADBE
$99.5B
$766K 0.32%
2,321
MSFT icon
57
Microsoft
MSFT
$3.45T
$747K 0.31%
4,739
-60
-1% -$8.81K
BMY.RT
58
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$720K 0.3%
+239,203
New +$622K
VRIG icon
59
Invesco Variable Rate Investment Grade ETF
VRIG
$1.8B
$644K 0.27%
25,808
+7,051
+38% +$176K
VT icon
60
Vanguard Total World Stock ETF
VT
$77.1B
$593K 0.25%
7,320
DES icon
61
WisdomTree US SmallCap Dividend Fund
DES
$2.18B
$566K 0.24%
19,745
-2,500
-11% -$69.7K
IAT icon
62
iShares US Regional Banks ETF
IAT
$674M
$532K 0.22%
10,445
ADC icon
63
Agree Realty
ADC
$9.34B
$476K 0.2%
6,780
PEP icon
64
PepsiCo
PEP
$190B
$451K 0.19%
3,298
+101
+3% +$13.7K
VNQ icon
65
Vanguard Real Estate ETF
VNQ
$39.2B
$436K 0.18%
4,703
-900
-16% -$83.3K
LLY icon
66
Eli Lilly
LLY
$1.02T
$421K 0.18%
3,200
+250
+8% +$29K
FTSM icon
67
First Trust Enhanced Short Maturity ETF
FTSM
$6.49B
$396K 0.17%
6,595
+90
+1% +$5.41K
RFDI icon
68
First Trust RiverFront Dynamic Developed International ETF
RFDI
$165M
$392K 0.16%
6,530
-1,070
-14% -$61.9K
LMT icon
69
Lockheed Martin
LMT
$134B
$391K 0.16%
1,003
+50
+5% +$19.2K
VTR icon
70
Ventas
VTR
$48B
$390K 0.16%
6,750
QTEC icon
71
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.52B
$388K 0.16%
3,875
-401
-9% -$37.4K
XLK icon
72
State Street Technology Select Sector SPDR ETF
XLK
$115B
$377K 0.16%
8,230
+1,020
+14% +$43.7K
TRP icon
73
TC Energy
TRP
$70.2B
$341K 0.14%
6,400
CVX icon
74
Chevron
CVX
$392B
$334K 0.14%
2,775
+150
+6% +$17.7K
DVY icon
75
iShares Select Dividend ETF
DVY
$23.5B
$332K 0.14%
3,145
+165
+6% +$17K

Similar funds

AlphaMark Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, AlphaMark Advisors held 546 positions worth $239M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

AlphaMark Advisors's Q4 2019 filing shows 36 new, 93 increased, 108 reduced and 33 closed positions. Its largest new stake was Alexion Pharmaceuticals: 29,481 shares worth $3.19M. The largest sale was Celgene Corp, an estimated $4.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Technology.

  • AlphaMark Advisors's largest Q4 2019 buy was Alexion Pharmaceuticals: 29,481 shares worth $3.19M.
  • AlphaMark Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.48M increase.
  • AlphaMark Advisors's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.91M.
  • AlphaMark Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $4.4M.
  • AlphaMark Advisors's ten largest holdings make up 35% of its $239M portfolio in Q4 2019.
  • AlphaMark Advisors opened 36 new positions and closed 33 in Q4 2019.
  • AlphaMark Advisors's portfolio value rose 3.6% quarter-over-quarter to $239M.

Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.